Denali Therapeutics Inc. (NASDAQ: DNLI), today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for tividenofusp alfa (DNL310) for the treatment ...
Emotional lashing out, chronic worry, depression, and self-harm are some of the mental health issues pediatricians are ...